A Phase 1, Open Label, Single Dose, Randomized, Cross-Over Study To Estimate The Effect Of Esomeprazole On The Pharmacokinetics Of Crizotinib In Healthy Volunteers.

Trial Profile

A Phase 1, Open Label, Single Dose, Randomized, Cross-Over Study To Estimate The Effect Of Esomeprazole On The Pharmacokinetics Of Crizotinib In Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jun 2012

At a glance

  • Drugs Crizotinib (Primary) ; Esomeprazole
  • Indications Bleeding ulcer; Gastro-oesophageal reflux; Helicobacter infections; Neuroblastoma; Non-small cell lung cancer; NSAID-induced ulcer; Peptic ulcer; Reflux oesophagitis; Solid tumours; Zollinger-Ellison syndrome
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 May 2012 Actual initiation date (May 2012) added as reported by ClinicalTrials.gov.
    • 29 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top